Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cipla
Medtronic
Julphar
Healthtrust
Merck
McKesson
AstraZeneca
Dow

Generated: February 17, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NEFAZODONE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Nefazodone Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00000286 Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3 Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 The purpose of this study is to determine the effects of nefazedone on cocaine self-administration in depressed and non-depressed female cocaine users.
NCT00000286 Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to determine the effects of nefazedone on cocaine self-administration in depressed and non-depressed female cocaine users.
NCT00000293 Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10 Completed University of Minnesota - Clinical and Translational Science Institute Phase 3 The purpose of this study is to determine the effect of nefazodone on relapse to cocaine use in depressed and non-depressed females with cocaine abuse/dependence.
NCT00000293 Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10 Completed National Institute on Drug Abuse (NIDA) Phase 3 The purpose of this study is to determine the effect of nefazodone on relapse to cocaine use in depressed and non-depressed females with cocaine abuse/dependence.
NCT00015210 Nefazodone in the Treatment of Cocaine Dependence and Depression - 4 Completed Boston University Phase 2 The purpose of this study is the use of Nefazodone in the treatment of cocaine dependence and depression comorbidity.
NCT00015210 Nefazodone in the Treatment of Cocaine Dependence and Depression - 4 Completed Boston Medical Center Phase 2 The purpose of this study is the use of Nefazodone in the treatment of cocaine dependence and depression comorbidity.
NCT00206765 Risperidone vs. Paroxetine for Panic Attacks Terminated Beth Israel Medical Center Phase 2 We are comparing the efficacy of Risperidone versus Paroxetine in the treatment of panic symptoms. The study hypothesis is that Risperidone will be a superior medicine for treating panic.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Nefazodone Hydrochloride

Condition Name

Condition Name for Nefazodone Hydrochloride
Intervention Trials
Cocaine-Related Disorders 3
Panic Disorder 2
Schizoaffective Disorder 1
Bipolar Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Nefazodone Hydrochloride
Intervention Trials
Disease 3
Cocaine-Related Disorders 3
Depressive Disorder, Major 3
Depressive Disorder 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Nefazodone Hydrochloride

Trials by Country

Trials by Country for Nefazodone Hydrochloride
Location Trials
United States 12
Israel 1
Canada 1
United Kingdom 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Nefazodone Hydrochloride
Location Trials
New York 4
Minnesota 2
North Carolina 1
California 1
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Nefazodone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Nefazodone Hydrochloride
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
Phase 2 7
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Nefazodone Hydrochloride
Clinical Trial Phase Trials
Completed 11
Recruiting 1
Terminated 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Nefazodone Hydrochloride

Sponsor Name

Sponsor Name for Nefazodone Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 3
Beth Israel Medical Center 2
University of Minnesota - Clinical and Translational Science Institute 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Nefazodone Hydrochloride
Sponsor Trials
Other 15
NIH 3
Industry 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Argus Health
Boehringer Ingelheim
Mallinckrodt
Daiichi Sankyo
Baxter
UBS
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.